Long-term safety of riluzole in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 3, Issue 1, 2002, Pages 23-29

  Lacomblez, L ^a   Bensimon, G ^a   Leigh, P N ^a   Debove, C ^a   Bejuit, P ^a   Truffinet, P ^a   Meininger, V ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Amyotrophic lateral sclerosis; Follow up study; Long term safety; Open label; Riluzole (Rilutek )

Indexed keywords

PLACEBO; RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; APNEA; ARTICLE; ASTHENIA; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSPNEA; EUROPE; FEMALE; HEALTH STATUS; HEART ARREST; HEART FAILURE; HUMAN; LONG TERM CARE; MALE; MULTICENTER STUDY; NAUSEA; NORTH AMERICA; PARALLEL DESIGN; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZATION; RESPIRATORY FUNCTION; RESPIRATORY FUNCTION DISORDER; SIDE EFFECT; CANADA; CHEMICALLY INDUCED DISORDER; HEMATOLOGIC DISEASE; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; POSTMARKETING SURVEILLANCE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SAFETY; UNITED STATES;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CANADA; CONSUMER PRODUCT SAFETY; EUROPE; FEMALE; HEMATOLOGIC DISEASES; HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGE; PRODUCT SURVEILLANCE, POSTMARKETING; RESPIRATORY TRACT DISEASES; RILUZOLE; UNITED STATES; HUMANS; MIDDLE AGED;

EID: 0035991267     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/146608202317576507     Document Type: Article

References (19)

1. The natural history of ALS in a specified population, with comments on risk factors, prognosis and symptomatic treatments
2. Amino acids as dietary excitotoxins: A contribution to the understanding of neurodegenerative disorders
3. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis
4. Excitotoxicity in ALS
5. The role of excitotoxicity in neurological disease
6. Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils
7. Neuroprotective actions of riluzole in rodent models of global and focal ischaemia
8. Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices
9. Neuroprotective effects of riluzole in ALS CSF toxicity
10. The pharmacology and mechanism of action of riluzole
11. Effects of riluzole on glutamatergic neurotransmission in the mammalian central nervous system and other pharmacological effects
12. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis
13. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis
14. A controlled trial of riluzole in amyotrophic lateral sclerosis
15. Dose-ranging study of riluzole in Amyotrophic Lateral Sclerosis
16. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole
17. The tolerability and AE profile of riluzole
18. Efficacy of riluzole in the treatment of amyotrophic lateral sclerosis